Navigation Links
Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer

Oral and pharyngeal cancers are by far the leading cancers in the world today. The problem is that these are not discovered until too late and thus the treatment, which includes radiation and surgery, involves // sacrificing a large amount of tissue leading to disfigurement.

Now two Virginia Tech researchers are collaborating with the American Dental Association (ADA) to build "a tissue engineered composite material for oral reconstruction." Brian Love, Virginia Tech professor of materials science and engineering, and principal investigator in this project stresses that they could provide "substantially better clinical outcomes for all oral constructions could result if a more viable scaffold material were used that was capable of faster and higher quality bone formation." His team is monitoring how amorphous calcium phosphates (ACPs) can play a role in the rebuilding of the lost tissue. "By constructing tissue engineered composites containing ACPs, living osteoblasts, and donor materials," Love said. The Paffenbarger Research Center of the ADA is providing the ACP required for this study. Aaron Goldstein of Virginia Tech's chemical engineering department, Drago Skrtic of the ADA Paffenbarger Research Center and Peter Shires of Virginia-Maryland Regional College of Veterinary Medicine are collaborating with Love in this particular venture. The details of this study are appearing in the forthcoming issues of the Journal of Biomaterials Science, Polymers Edition, and the Journal of Biomedical Materials Research. Contact: Lynn Nystrom tansy@vt.edu 540-231-4371 Virginia Tech
'"/>




Page: 1

Related medicine news :

1. New Study Will The Look Into The Effects Of Synthetic Steroids
2. Synthetic protein found to relieve arthritis symptoms in animal model
3. A Synthetic Molecule Instigates Cancer Cells To Self-Harm
4. Synthetic DNA Makes Better Hydrogels for Drug Delivery
5. Super Chow, Laced With Semi-Synthetic Vitamin E, Inhibited Spread of Cancer
6. Synthetic Chemicals May Trigger Breast Cancer
7. Synthetic Cannabinoid Could Improve Fertility in Smokers
8. Chemicals Used To Make Synthetic Color Can Cause Cancer And Permanent Blindness
9. Free Tissue Transfer Effective in Treating Massive Skin Cancers
10. Tissue Transfer for Skin Cancer
11. Tissue Transfer For Treatment Of Massive Skin Cancers

Post Your Comments:
(Date:11/8/2009)... UCW Academy of Health holds open ... Victoria, BC (Vocus) November 8, 2009 -- UCW Aca...areer in British Columbia’s health care indu...nesday, November 25, 2009. , ,UCW Academy of Heal...tration, nursing and social services, designs its ...
(Date:11/8/2009)...HINGTON, Nov. 8 Speaker...conference following the House passage of H.R. 396...e bill passed by a vote of 220 to 215. Below are ...of my colleagues just received a call from the Pre...ulating us on a great victory for the American peo...
(Date:11/8/2009)... 3D Global Solutions is pleased to...anaging the proposal effort for ReSound who recent...l Hearing Aid contract. The award includes not onl...ment of Defense and other federal agencies. , ... 8, 2009 -- 3D Global Solutions is pleased to anno...
(Date:11/8/2009)... A jury of 8 people in the Western...oman $2,300,000 in pain and suffering for a medica...es Tallman and Alicia Nocera of Thomas E. Crenney ...the plaintiff, Vita Monestersky and against the Un...ncy total abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)...tion,s largest network of Hispanic health advocate...form in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire...ntatives showed they have heard the voice of Ameri...e for America Act. Now the Senate must deliver, wi...are reform," said Dr. Jane L. Delgado, President a...
Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...bine Online Education with On-Site Clinical Prepar...IANAPOLIS, March 10 In response to a growing shor...day Marian College and St.Vincent Health announc...e first of its kind in Indiana to incorporate lead...
...rch 10 A diverse coalition of clergy and lay memb...a press conference today to call on U.S. Senators ...Iowa congressional delegation to support legislati... last session of Congress, Senator Grassley was no...
...J., March 10 The Institute for Patient Blood Mana...y the NJ Institute for Bloodless Medicine and Surg...brates its 15th anniversary this year. The new nam...1994 inception of the Institute, Englewood Hospita...
...body weight and sustained it for 6 months, study f...) -- A 12-week church-based weight loss program he...r more of their body weight, and most of them main...They took part in a pilot program conducted by lay...
...arch 10 Representatives Gene Green (D-TX), Ed Whi...Diana DeGette (D-CO), Mike Rogers (R-MI), Betty Su...and Ralph Hall (R-TX) today introduced H.R. 1392. ... the Medicare Program by excluding customary promp...
...mpuCyte Corporation and the Program in Cellular an... (also known as the Immune Disease Institute) toda...ive Imaging Cytometry program. The Program in Cel...reement, CompuCyte will make its proprietary laser...
Other Medicine News:Health News:Marian College and St.Vincent Health Announce Collaboration To Address Nursing Shortage in Indiana 2Health News:Marian College and St.Vincent Health Announce Collaboration To Address Nursing Shortage in Indiana 3Health News:Faith Leaders Call on Iowa Members of Congress to Support Legislation to Protect Kids from Tobacco 2Health News:Faith Leaders Call on Iowa Members of Congress to Support Legislation to Protect Kids from Tobacco 3Health News:Englewood Hospital Marks 15 Years of Leadership in Improving Patient Outcomes Through Bloodless Medicine and Surgery 2Health News:Englewood Hospital Marks 15 Years of Leadership in Improving Patient Outcomes Through Bloodless Medicine and Surgery 3Health News:Church-Based Weight Plan Peels Off Pounds for Blacks 2Health News:House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill 2Health News:House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill 3Health News:CompuCyte Corporation and Program in Cellular and Molecular Medicine at Children's Hospital Boston Announce Joint Program for Quantitative Imaging Cytometry Research Services 2
(Date:11/6/2009)...SEARCH TRIANGLE PARK, N.C., Nov. 6 ...cing orally-available antiviral therapeutics to ad... on the development of the company,s lead antivira...on (WHO) and the Global Health Security Initiative...nt being developed for the treatment of smallpox, ...
(Date:11/6/2009)...TROIT, Nov. 6 Caraco Pha...has launched ketorolac tromethamine ophthalmic sol... Food and Drug Administration (FDA) for Sun Pharma...eric Acular® opthalmic solution on the first ...ketorolac is therapeutically equivalent to Acular&...
(Date:11/5/2009)...N DIEGO, Nov. 5 Althea Technologi...nufacturing services for biopharmaceutical product... Development to the company,s platform of services.... James Matsuura, Director of Formulation Developm...mulation and analytical scientists, along with new...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Commonwealth Fund Case Study Points to Continuous Innovation at Group Health Cooperative 4643 1Commonwealth Fund Case Study Points to Continuous Innovation at Group Health Cooperative 4643 2Commonwealth Fund Case Study Points to Continuous Innovation at Group Health Cooperative 4643 3National Day of Health Care Service 49961 1Tyco Electronics Appoints Cuong Do as Senior Vice President Corporate Strategy 26 Business Development 49958 1Tyco Electronics Appoints Cuong Do as Senior Vice President Corporate Strategy 26 Business Development 49958 2
...SAN MATEO, Calif., Oct. 3 Anthera Pharmaceuticals...developing,anti-inflammatory therapeutics for chro...y the completion of enrollment and patient dosing ...d, A-002 for stable coronary,artery disease. Data ...f,the year. "We are pleased with the rapid enroll...
...NEW YORK, Oct. 2 ImClone Systems Incorporated,(Na...SE: BMY ) today announced,that the U.S. Food and ...o,the ERBITUX(R) (Cetuximab) product labeling to i...epidermal growth factor inhibitor,(EGFR)-expressin...er,failure of both irinotecan- and oxaliplatin-bas...
Other Medicine Technology:Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease 2Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 2Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 5Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 6Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 7
...Quant Rapid Opiate II Rapid Opiates is an immunoch...esigned for qualitative determination of Opiates a...esence of morphine in human urine above a cut-off ...s not been evaluated in the point of care,location...
Methadone - Rapid Test
Amphetamine - Rapid Test
... Applied Biosystems introduced the completely auto...yzer.,Now the innovative technology of the 3100 ...ABI PRISM 3100-Avant Genetic,Analyzer. Designed ...e fully automated 3100-Avant system can analyze,...
Medicine Products: